A B S T R A CT Tissue localization of antihemophilic factor (AHF, factor VIII) antigen and fibrinogen by immunofluorescent microscopy was determined in 146 specimens of normal and diseased kidneys. AHF antigen was present in the endothelial cells of glomeruli, peritubular capillaries, arteries, and veins of normal kidneys; a distribution similar to that in other tissues. In scleroderma and malignant hypertension, deposition of AHF antigen and fibrinogen was limited to the markedly thickened endothelial layers of arteries. More extensive intense deposition of both AHF antigen and fibrinogen in glomeruli and in arterial walls were present in hyperacute renal homograft rejection, hemolyticuremic syndrome, postpartum renal failure, and in some cases of acute homograft rejection. In contrast, deposition of fibrinogen was observed in glomerular epithelial cresents in severe proliferative glomerulonephritis, but AHF deposition was not present in these lesions. Glomerular deposition of fibrinogen without increased AHF standing was also detected in renal tissue from patients with anaphylactoid purpura nephritis and in recurrent macroscopic hematuria with focal glomerulonephritis. Received for publication 20 September 1973 and in revised form 12 December 1973. experimental renal diseases (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . In addition, fibrin degradation products have appeared in the blood and urine of patients with glomerulonephritis and in renal transplant recipients (11, 12) . How fibrinogen is deposited and fibrin degradation products are produced in renal disease have not yet been established; and the precise role of coagulation proteins in the pathogenesis of renal failure is still unknown. The tissue distribution of antihemophilic factor (AHF, factor VIII)1 antigen (13) and fibrinogen in human renal diseases has been determined in the present study to obtain additional information about the possible involvement of the coagulation system in their pathogenesis. These immunohistologic studies of human kidney biopsy specimens indicate that fibrinogen may be deposited in human renal diseases through multiple pathways.
METHODS
The tissues which were examined included 100 consecutive renal specimens obtained during a 3-mo pentane prechilled in liquid nitrogen and stored at -70'C until sectioned. 4-,um thick sections were cut in a cryostat and stored at -20'C for a period no longer than 3 mo before staining. Sections were stained with fluorescein-conjugated monospecific antisera prepared in our laboratory FIGURE 1 The intense staining for AHF in peritubular and interstitial capillaries demonstrates the vascularity of this "end-stage kidney" (X 120).
to human IgG, IgM, IgA, C3 (,B-1C globulin), fibrinogen, and albumin by the direct technique as previously described (14, 15) . Sections were stained with rabbit antihuman AHF and rabbit antihuman a-2 macroglobulin by the indirect technique using fluorescein-conjugated monospecific goat antirabbit IgG as previously described (13) . This latter antiserum had been absorbed previously with human IgG and reacted only with rabbit IgG. Specific staining of normal and pathologic human tissues with the rabbit anti-AHF was blocked by absorption of the antisera with highly purified AHF (16) or with an ethanol concentrate of normal human plasma, but not by an ethanol concentrate of plasma from a patient with von Willebrand's disease or with human fibrinogen (13) . The antiserum to a-2 macroglobulin was purchased from Behring Diagnostics (Woodbury, N. Y.). Most specimens were examined by transmitted fluorescence using a Zeiss microscope (Carl Zeiss, Inc., New York) equipped with an HBO 200 W light source and a BG12 excitation filter, or, in some instances, an FITC interference filter. More precise cellular localization of positive staining in some sections was obtained using phase contrast immunofluorescence with indirect fluorescence illumination in a Zeiss Ultraphot II microscope. This was particularly helpful in identifying endothelial cells and/or mesangial cells of glomeruli. AHF and fibrinogen deposition within arteries. Marked endothelial proliferation was noted in renal biopsy specimens from two patients with scleroderma and one patient with malignant hypertension (Table I, pattern I). It was apparent on light microscopy that the endothelial lesions completely occluded the lumens of some vessels. These arteries stained strongly for AHF and fibrinogen within the endothelial layers (Fig. 2D) , although a single well-organized thrombosed artery in one specimen was negative. Abnormal AHF staining and fibrinogen deposition were not detected in glomeruli of these sections and both arteries and glomeruli were (Table II) . In each instance, the kidney was removed within 24 h of (Table III) . Each patient was azotemic (serum creatinine of 3 mg/ 100 ml or greater). All specimens had evidence of homograft rejection by light microscopy with interstitial edema and/or fibrosis, lymphocyte and plasma cell infiltration, and endothelial proliferation within arteries. Intense staining with anti-AHF and antifibrinogen was observed throughout the walls of one or more arteries and in thrombosed vessels of four specimens and within the thickened arterial endothelium of a fifth specimen (Table III) . Glomerular capillary staining for AHF and fibrinogen was more focal and less intense in most instances. Intense IgM staining with the same distribution as that of AHF and fibrinogen was observed in only one of these five specimens (patient L. D.). Other specimens contained nodular deposits of IgM (and C3) in the outer layers of arterial walls without similar AHF or fibrinogen deposits. AHF and fibrinogen deposition was not present in the biopsy specimen of patient J. B. whose subsequent transplant nephrectomy specimen (1 mo later) showed intense deposition of both proteins in the walls of thrombosed arteries. Similar findings were also observed in tissue from two patients with hemolytic-uremic syndrome and in a woman with postpartum renal failure (Table II) . Specimens from both patients with the hemolytic-uremic syndrome were obtained 2 wk after onset of the disease. Intense deposition of AHF, fibrinogen, and IgM was seen along glomerular capillary walls, within glomerular capillary thrombi, and throughout arteriolar walls (Fig.  4) , 3 mo later, one patient's kidneys were removed because of severe hypertension not controlled by hemodialysis. Arterial endothelial proliferation with an onionskin appearance was apparent by light microscopy of the nephrectomy specimens, and intense staining for AHF and fibrinogen was regularly present in the thickened endothelial layers of these vessels ( Figs. 2A and   B ). Only one of these lesions had positive staining for IgM and none of these arteries showed positive staining for a-2 macroglobulin. It should be noted that the positive staining of arteries in these specimens with anti-C3 was granular and did not correspond in distribution with that of AHF and fibrinogen.
RESULTS

Normal tissues
Renal tissue from a patient with postpartum renal failure after preeclampsia and abruptio placentae was obtained 2 wk after delivery. All glomeruli showed intense staining for AHF, fibrinogen, and IgM, but not for other proteins (Fig. 4D) . Whereas some arteriolar walls had focal positive staining for coagulation proteins and IgM, no AHF or fibrinogen deposition was identified within large arteries.
Fibrinogen deposition in the absence of increased AHF staining. In contrast to the close correspondence between the deposition of AHF and fibrinogen in diseases described above, there was a clear dissociation of fibrinogen deposition from that of AHF in severe proliferative glomerulonephritis with crescent formation. The eight patients with crescentic glomerulonephritis studied included two patients with Goodpasture's syndrome, two with Wegner's granulomatosis, two with rapidly progressive glomerulonephritis with granular immunoglobulin and complement deposition, one with hypersensitivity angiitis, and one with systemic lupus erythematosus nephritis. In each of these specimens, intense staining with antifibrinogen was present within the epithelial crescents of glomeruli (Figs. 5A and C). In these same glomeruli, positive staining for AHF was present within the glomerular capillary tufts but never in the crescents (Figs. 5B and D) .
Dissociation of glomerular deposition of fibrinogen from that of AHF was also apparent in renal tissue from some patients with anaphylactoid purpura nephritis as well as patients with focal glomerulonephritis with recurrent macroscopic hematuria (Table I ). Although precise glomerular localization was often difficult to establish, staining for fibrinogen in the specimens from patients with anaphylactoid purpura appeared to be predominantly within endothelial cells and along peripheral capillary loops. In one of the patients with recurrent macroscopic hematuria, glomerular fibrinogen staining was primarily within the mesangium; there was no AHF deposition in this site. 
Other diseases
In contrast to the patterns described above, no deposition of fibrinogen, or very weak staining compared with that of other serum proteins, was observed in glomeruli and arteries of 89 additional specimens. Most of these specimens were examined during the prospective study of 100 consecutive specimens received in our laboratory to gain further information about the specificity of altered AHF staining. endothelial cells, without fibrinogen deposition, was limited to renal tissue from three patients with acute glomerulonephritis and in two of four patients with steroidresponsive idiopathic nephrotic syndrome. Even though there was distortion of glomerular architecture, as in amyloidosis and chronic membranoproliferative glomerulonephritis, AHF staining was limited to peripheral capillary loops in these specimens.
DISCUSSION
Evidence that coagulation mechanisms and fibrin deposition play a role in renal disease is derived from several sources and has recently been reviewed in detail (1) . The mechanism by which fibrinogen is deposited in renal disease has not been established, however, and the precise role of this protein in the pathogenesis of renal failure is unknown. Studies of other coagulation proteins may give insight into these mechanisms. Since antihemophilic factor is an essential component of the intrinsic coagulation pathway, evidence for participation of the coagulation system in the pathogenesis of renal diseases has been sought through immunohistologic study of AHF antigen.
The preparation of monospecific rabbit antisera to highly purified human antihemophilic factor has made it possible to define more clearly the physiologic regulation and synthesis of this coagulation protein (13, (17) (18) (19) (20) . In one of these studies, we have used immunofluorescent microscopy to identify AHF antigen in endothelial cells throughout the body (13) . Tissue culture studies have verified this observation and have demonstrated AHF antigen synthesis by endothelial cells (20) . Definition of antiserum specificity is essential for the interpretation of these studies and detailed evidence has been presented which demonstrates the monospecificity of the rabbit anti-AHF (13, 18) . The protein which reacts with this antiserum can also be characterized by its two functional properties. Both antihemophilic factor procoagulant activity and "von Willebrand's factor activity" are inactivated by the rabbit antiserum (17, 18, 21) . This inactivation, taken together with additional studies of the immunologic properties of anti-AHF (22) , strongly suggest that this antiserum identifies the tissue localization of both AHF and von Willebrand's factor in these immunofluorescent studies (13) .
The localization of AHF antigen in renal tissue has been compared with that of antigens which react with rabbit antihuman fibrinogen. Although antifibrinogen reacts with a single protein in normal human plasma, it does not differentiate this protein from other molecules which share antigenic determinants with fibrinogen (fibrin and the fibrinolytic degradation products of fibrinogen and fibrin). In this report these deposits are designated fibrinogen, the immunizing antigen, but the imprecise nature of this designation is recognized.
Intense staining with anti-AHF in a distribution similar to that of antifibrinogen was observed in glomeruli and/or arteries of renal tissue from patients with hyperacute homograft rejection, acute homograft rejection, hemolytic-uremic syndrome, postpartum renal failure, scleroderma, and malignant hypertension (Table I , patterns I and II). Proteins other than IgM were infrequently found in these tissues and then only in small quantities. It is possible, therefore, that the similar patterns of AHF and fibrinogen antigens reflect the involvement of the coagulation sequence. The basis for the IgM deposition (Table II) , similar in distribution to that of AHF antigen and fibrinogen, is not known. It is possible that IgM initiates endothelial injury in these diseases and that the localization of coagulation proteins follows from this immunologic reaction. An alternative possibility, entrapment of large plasma proteins (IgM and AHF) within the fibrin coagulum, should also be considered. However, a protein with similar dimensions, a-2 macroglobulin, was not detected in these lesions. The rarity of IgM deposition in another site of AHF and fibrinogen deposition, arterial endothelial proliferative lesions, also supports the conclusion that AHF localization is not due to entrapment.
The precise mechanisms leading to the patterns of abnormal AHF antigen deposition have not yet been established. AHF localization may reflect the participation of this molecule in the coagulation sequence since the antigenic properties of the molecule are preserved during coagulation despite loss of procoagulant function (17, 18) . Breakdown in vascular integrity and subsequent diffusion of plasma AHF antigen into (and fixation within) extravascular sites could also lead to abnormal AHF antigen localization. For example, this mechanism is consistent with other features of the pathophysiology of hyperacute homograft rejection. Injury to the vascular endothelium, and thus the endothelial cells which are responsible for AHF antigen synthesis, might also lead to tissue deposition of AHF antigen. This sequence may be responsible for AHF localization in renal diseases in which there is marked endothelial cell hyperplasia.
In contrast to the parallel AHF and fibrinogen deposition in diseases with staining patterns I and II (Table I), the glomerular epithelial cell crescents of severe proliferative glomerulonephritis were intensely stained by antifibrinogen but not by anti-AHF. Although the mechanisms by which proteins with fibrinogen antigens are deposited in crescents are not known, the absence of AHF antigens in this site suggests that a different process, unrelated to coagulation, may be involved. More precise characterization of the fibrinogen-related proteins deposited in crescents is essential for a better understanding of the nature of these lesions. Antisera which specifically identified the degradation products of fibrinogen and fibrin (23) will be useful in future immunohistologic studies of crescents and other glomerular lesions in which fibrinogen antigen deposition is seen without AHF deposition. The presence of platelets in lesions may also be important since immunohistologic-studies cannot distinguish fibrinogen intimately associated with the platelet surface from plasma-derived fibrin or its degradation products (24) .
Another distinct immunofluorescent pattern, increased peritubular capillary staining with anti-AHF (Fig. 1 (25, 26) , suggest that the coagulation sequence may be involved in some renal diseases. Endothelial injury, in some instances the result of immunologic reactions, may expose portions of glomerular basement membranes and other collagen-like proteins in arterial walls to the plasma protein, Hageman factor, and thereby initiate coagulation through the intrinsic pathway. The patterns of AHF antigen and fibrinogen deposition described here in diseases characterized by endothelial injury suggest that coagulation mechanisms participate in the pathogenesis of some human renal diseases. Although a preliminary classification has been made possible by immunofluorescent studies, more precise definition of the pathophysiology remains a goal for future investigation.
